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Abstract:  
 Proper regulation of neutral lipid storage (lipogenesis) and release (lipolysis) are 
critical molecular processes localized to an organelle called the Lipid Droplet (LD). The 
LD consists of a core with neutral lipids such as triacylglycerols (TAGs) and sterol 
esters surrounded by a phospholipid monolayer.1 Dysregulation of the processes 
localized to the LD are involved in the pathology of various diseases such as Neutral 
Lipid Storage Disease, diabetes, stroke and cancer.2,3,4 The non-enzymatic protein 
ABHD5 (α-β Hydrolase Domain-Containing Protein 5), is thought to play a key role in 
the process of lipolysis by forming homo-oligomers on the surface of the LD that create 
packing defects on phospholipids and allowing the TAGs to be liberated by another 
protein called PNPLA2 (Patatin-Like Phospholipase Domain-Containing Protein 2). The 
goal of my research is to understand how ABHD5 changes the morphology of 
membranes by using various model membrane systems. Localization of the protein to 
the membrane and morphological changes of the lipids are visualized with 
epifluorescence microscopy.  Results from this study will enable us to understand how 
lipolysis is regulated via protein interactions with lipid membranes to induce functional 
lipase activation perhaps through inducing membrane shape change. 
Introduction:   
 Lipid membranes play a very important role in human health. They are the 
substrates which regulate many different processes inside cells such as the firing of a 
neuron, signal transduction through G-Protein coupled receptors, and the 
inter/intracellular export and import of different substances. The system I studied in this 
project is the membrane interface of the Lipid Droplet and the Endoplasmic Reticulum 
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(ER). The ER is a branched organelle found inside eukaryotic and prokaryotic cells that 
is responsible for the production of proteins and lipids. It spans a large part of the cell 
and is continuous with the nuclear envelope.5 It is of particular interest in this project 
because the ER is the site of biogenesis of the LD.1 Neutral lipids are synthesized in 
between the leaflets of the bilayer by proteins through an esterification reaction followed 
by an acyltransferase reaction. When sufficient neutral lipid has been synthesized, a 
lens like protrusion will form. As more neutral lipid aggregates, a bud like structure will 
start to take shape. It is thought that the neutral lipid wanting to minimize contact with 
aqueous solution helps to drive the formation of the bud.1 With the help of the FIT 
protein, the bud detaches from the ER.1 
 Lipolysis is the reaction in which fat is broken down and released. The main 
protein behind this activity is PNPLA2, an enzymatic protein that hydrolyzes TAG to 
DAG leading to the release of a fatty acid. However, it is not the only protein in the 
mechanism. ABHD5 is a non-enzymatic protein that plays a vital role in this process.  
Previous work from our collaborator, Dr. James Granneman, showed that even though 
ABHD5 lacks a nucleophilic serine group required for hydrolase activity, it plays a very 
important role in lipolysis.6 It is thought that ABHD5 may play a role in lipolysis by 
oligomerizing on the surface of the membrane and creating sites of curvature (Figure 1). 
These sites of curvature create packing defects in the membrane allowing PNPLA2 to 
enter and release fatty acids. The goal of my project was to test this hypothesis by 
adding ABHD5 to three different model membrane systems, Supported Lipid Bilayers 
(SLB), Artificial Lipid Droplets (aLDs), and Droplet Embedded Vesicles (DEVs), and 
looking for morphological changes in the shape of the membrane.  







Figure 1: Cartoon that demonstrates ABHD5 oligomerizing on the surface of the LD inducing 
curvature. This curvature creates packing defects in the phospholipid monolayer exposing TAG 
to the enzymatic protein PNPLA2 which hydrolyzes and releases a fatty acid. 
 
Project 1: Supported Lipid Bilayers   
Introduction:    
 Model membrane systems are very useful in trying to understand the key 
underlying phenomenon in biological membranes without the complexity involved with 
cells. An SLB consists of the fusion of a bilayer to a substrate, typically glass. To learn 
more about how ABHD5 interacts with sites of curvature, I aimed to induce the 
formation of tubules and buds from the SLB following a published protocol.7 Tubules 
and buds are protrusions of the membrane up away from the glass simulating curvature 
found in the real Lipid Droplet and Endoplasmic Reticulum. After the formation of 
tubules and buds, ABHD5 was added to see types of morphological changes that are 
occurring and if the protein is preferentially binding to the tubules and buds. 
Methods:  
 There are two main components in the process of forming buds and tubules from 
SLBs. The first step is to form spherical membrane structures called Large Unilamellar 
Vesicles (LUVs). The LUVs are to be added to the glass of a 96 well plate, where they 
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fuse and form an SLB as (Figure 1). The second step involves changing the buffer to 
induce the formation of buds and tubules (Figure 2).  
 A mixture of 55% DOPC (w/w) ,25% DOPE (w/w), 20% DOPS(w/w) , and 1% 
(w/w) of the fluorophore Cy5-PE were mixed together in a vial; all lipids were bought 
from Avanti Polar Lipids®. The mixture was then dried off with nitrogen gas and 
resuspended in 1 milliliter of 1 M NaCl for a final lipid concentration of 0.2 mg/ml. The 
lipid mixture was then passed through a liposome extruder with a 50nm filter. This 
process formed the LUVs, each with a diameter of 50nm. A 1M NaOH solution was 
deposited on the glass followed by a rinse with mQ water to remove any impurities on 
the glass. To ensure binding of the LUVs with the substrate, 1 μl of CaCl2 was added to 
the glass. To form the SLB, 40 µl of the extruded LUV solution was added to the well 
and left to incubate for 20 minutes. During this time the LUVs are making impact and 
bursting onto the glass. In this process often excess bilayers and lipid chunks are 
deposited on the glass; to remove them, a micropipette aspirator was used to rinse the 
sample 8-10 times with 1M NaCl in conjunction with a suction vacuum to collect said 
waste. The SLB will look quite uniform with some bright spots indicating the lipid chunks 
that were not able to be rinsed away (Figure 2). After the formation of the SLB, the 1M 
NaCl solution was switched out for mQ water and left to sit in the well for 1-2 minutes. 
This was followed by an exchange of the water for a HEPES buffer; this exchange of 
buffer led to the formation of lipid buds and tubules which can be seen as the large 
spherical structures and elongated structures that are partially out of the plane of focus 
respectively (Figure 2). The ABHD5 protein was diluted from a 39mM stock solution 
suspended in Intracellular Buffer (IB) to 2mM with HEPES buffer. The protein was 
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added into the well with a micropipette; proper protein mixing was ensured by pulling 
and releasing liquid multiple times in the sample. The control experiment consisted of 
the addition of HEPES buffer only to the tubules and buds acting a vehicular control. 
 All imaging was done with an inverted IX71 Olympus Fluorescence Microscope. 
The basic principle behind fluorescence microscopy is that certain molecules absorb 
one wavelength of light and emit a different wavelength of light. When a specific 
wavelength of light is incident on a sample, the electrons in the fluorescent molecule are 
excited to a higher energy level: in that energy level there are many vibrational states 
the electron can be in. Upon excitation, the electron recedes to a lower vibrational state 
in the excited energy level (Figure 3).  From this lower vibrational state, the electron falls 
back down to ground state, emitting a longer wavelength of light; this can be explained 
by the Planck-Einstein Relation, ∆E=hc/∆λ, where the change in energy is inversely 
proportional to the change in wavelength. The lipids and ABHD5 were tagged with the 
fluorescent molecules Cy5 and mCherry respectively. Lipids and proteins were imaged 
through LED with excitation cubes of 647nm and 561nm respectively (Figure 4). After 
data acquisition images were analyzed using image analysis software ImageJ. 
Results and Discussion:  
 The formation of just the SLB sample was a feat that proved to be very difficult. 
In the early stages of the process, either too much lipid was being incorporated into the 
sample, leading to large chunks of lipid being concentrated on the membrane or too 
little lipid was being incorporated due to the harsh washing technique. This process was 
quite iterative and was a matter of trial and error till the most appropriate settings on the 
micropipette aspirator were found which controlled the flow of liquid just right removing 
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the large chunks of lipid without ruining the membrane. To induce the membrane buds 
and tubules, a protocol from a paper by Knight et al. was followed. The authors state 
that to induce the formation of buds and tubules, excess lipid needs to be incorporated 
into the sample followed by a salt exchange leading to the protrusion of the membrane.7   
 To properly incorporate excess lipid in the sample, the rate at which the 
liposomes adsorb to the substrate needs to be larger than the rate at which they are 
rupturing.7,8 This is because as the liposomes adsorb to the surface faster than they 
rupture, more lipid can be incorporated on substrate as there is available surface area.  
A study done using SUPER template assays found that an increased concentration of 
NaCl leads to a larger amount of membrane being incorporated into the template.8 A 
sample with a concentration of 1mM NaCl compared to 1M NaCl had 2.4-fold less lipid 
incorporated. The mechanism behind this is not yet understood, however, the authors 
argue that the salts play a large role in the kinetics of the liposome adsorption and SLB 
formation. The authors also demonstrate that samples with large amounts of DOPS 
leads to more robust SLB formation. They explain this phenomenon as the silica beads 
which the membrane is wrapped around has repulsive effects with negatively charged 
DOPS encouraging the excess membrane to spill out and form an SLB. The DOPS 
preferentially binding to the glass substrate in my SLB system makes sense as the 
surface is intentionally made hydrophilic to encourage this behavior. To complete the 
process and induce tubule and bud formation the buffer had to be switched out from 
NaCl to mQ water followed by another buffer exchange to HEPES. This is because the 
switch from water to a physiological buffer causes the membrane to expand laterally 
and fill in microscopic defects in the SLB.7 Once these have been filled, the excess 
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membrane with nowhere to go protrudes upwards in the z-plane forming buds and 
tubules. This process is favorable because introduction of HEPES into the solution (i.e. 
salts back into the sample) leads to a decrease in the Van der Waal forces between the 
leaflets of the bilayer. To minimize this “energetic cost”, a “new equilibrium” is reached 
by the swelling of the membrane; this helps with the formation of buds and tubules in 
the SLB.8 
 The control experiment shows that both the bud and the tubule maintain their 
shape after having the HEPES buffer added and mixed into the sample (Figure 5). This 
indicates that the flow of the liquid from the pipette into the sample is not causing shape 
changes. However, when the ABHD5 is added to the buds and tubules drastic 
morphological changes appear. The addition of ABHD5 to a tubule structure leads to 
the breakdown and formation smaller vesicles; the original structure of the tubule is 
completely altered (Figure 6). Furthermore, looking at any one of the smaller vesicles, 
they are getting brighter over time indicating that the protein is sorting to these sites. 
Similar results are seen, when the protein is added to the sample with a bud (Figure 7). 
The bud immediately fractures into many small pieces, resembling a pearl necklace. 
These morphological changes on sites of curvature indicate that the ABHD5 is 
interacting with the membrane and supports the hypothesis of the non-enzymatic 
protein causing physical remodeling of the membranes. Observing the protein channel 
shows that the protein is aggregating to the sites of curvature preferentially indicated by 
the increase in fluorescence (Figures 6 and 7). The idea that this increase in brightness 
could be due to the protein mixing and settling into the sample over the period of 
imaging is negated by the fact that the protein is thoroughly mixed into well prior to 
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imaging. Furthermore, all images were acquired following control experiments for 
bleedthrough and imaging parameters both during imaging and in analysis afterwards 















Figure 2: (Left) SLB (55% DOPC, 25% DOPE, 20% DOPS, 1% CY5) made by LUV fusion on 
glass substrate after excess lipids have been rinsed away. (Right) The SLB after a solvent 
exchange from mQ water HEPES buffer leading to the formation of buds and tubules. Both 
images were taken with 𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence. 














Figure 3: Jablonski Diagram 
demonstrating how an electron is 
excited to a higher energy level and 
then relaxes vibrationally followed by 
a return to ground state emitting a 
longer wavelength of light.9 
Figure 4: Excitation/Emission spectrum showing 
how light is absorbed at one wavelength and 































Figure 7: Addition of ABHD5 to a bud shows vesiculation and drastic membrane 
remodeling. (Top) CY5 imaged with 𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence.(Bottom) 
ABHD5 imaged with 𝜆𝑒𝑥𝑐 =  561𝑛𝑚 epifluorescence. 
 
Figure 5: Time lapse vehicular control experiment, via the addition and 
mixing of HEPES buffer to buds and tubules, shows stability in the shape 
of bud and tubule after addition of buffer. Both sets of images taken with 
𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence. 
Figure 6: Addition of ABHD5 to tubule shows vesiculation and drastic 
membrane remodeling. Time lapse shows that vesicles get brighter due to 
protein sorting. (Top) CY5 imaged with 𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence. 
(Bottom) ABHD5 imaged with 𝜆𝑒𝑥𝑐 =  561𝑛𝑚 epifluorescence. 
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Project 2: Artificial Lipid Droplets  
Introduction:  
 Artificial Lipid Droplets (aLDs) are another synthetic 
model membrane system used to study the properties of 
membranes. They differ structurally from SLBs in that they 
consist of an oil filled center, typically triacylglycerol, 
surrounded by a monolayer of phospholipids (Figure 7). I 
conducted a very similar experiment with this apparatus, 
where I added in ABHD5 to the aLDs and looked for 
morphological changes and preferential sorting of ABHD5 to the sites of curvature. The 
reason this system was chosen is because the structure of an aLD, as the name 
implies, is very representative of real LDs.  
Methods:  
 To prepare the artificial lipid droplets, I mixed DOPC and the neutral lipid Triolein, 
purchased from Avanti Polar Lipids®, in a small Eppendorf tube at a mass ratio of 500:1 
respectively. This tube was then placed in a bath sonicator for 30 minutes; this process 
helped to mix the phospholipids and triolein to form the aLDs. To view the aLDs, I used 
a microscope glass slide and cover slip. The glass slide was rinsed with ethanol and 
was passivated with a casein solution for at least 20 minutes then rinsed thoroughly by 
mQ water. The glass passivation helps to ensure the aLDs stick to the glass and do not 
fuse to each other. After the glass was passivated 5 µl would be place on the slide 
followed by 1 µl of 20 µm 1:100 diluted silica beads. The beads ensure there is proper 
Figure 7: Structure of an 
Artificial Lipid Droplet.11 
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spacing between the cover slip and the 
glass slide. ABHD5 was added to the 
slide at a 1µl volume at a concentration 
of 50nM: this concentration is more 
physiologically relevant as shown in a 
lipolysis assay done by our collaborator 
(Figure 8), Dr. Matthew Sanders. A cover slip 
was then placed on the glass slide and 
sealed with vacuum grease to ensure that it 
does not detach from the slide. Images were 
taken with the IX71 fluorescence microscope both with LED and white light 
transmission. The DOPC was tagged with DOPE-CY5 and the ABHD5 was tagged with 
the fluorophore CFP. The ABHD5 was allowed five minutes to bind prior to imaging. 
Results and Discussion:  
 The results of the experiment where ABHD5 was added to the sample was a bit 
shocking. After seeing the drastic changes induced by in the SLB sample, I anticipated 
a similar result in this system. However, after comparing images of the aLDs with 
protein to the images of the aLDs without protein, no distinguishing physical changes 
are visible (Figure 9). Specifically, I was looking for the circularity of the aLDs to change 
because if ABHD5 was oligomerizing on the surface and exposing packing defects, we 
would expect some deformities in the shape of the membrane to be present.  
 One explanation for this phenomenon could be the lack of excess phospholipids 
surrounding an aLD. The neutral core of lipids is surrounded by phospholipids, and I am 
Figure 8: A binding isotherm curve 
created by our collaborator, Dr. Matthew 
Sanders, describing the various 
concentrations of ABHD5 at which fatty 
acids are released in a lipolysis assay. 
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looking for deformations in the shape of monolayer. However, if there are only enough 
phospholipids to just surround the aLD, then it is possible that membrane protrusions or 
physical changes will not be present. Recall that in the SLB sample, for membrane 
tubules and buds to form, there had to be some excess lipid present on the substrate 
that could protrude up. In this situation, any excess phospholipids that are incorporated 
in the process of aLD formation could be leaving the aLD as the phospholipids prefer to 
be in water by themselves rather than sequestered at the aLD. Another factor that could 
be explaining the lack of visible physical changes could be the time given to incubate 
the ABHD5. In this experiment I gave the ABHD5 only 5 min after being plated with the 
aLDs before imaging. A longer period of incubation could allow for more aggregation 
and oligomerization of the ABHD5 on the surface of the aLD. To improve this 
experiment, I would like to first try increasing the incubation time of ABHD5. Another 
step to potentially improve the experiment is changing the TAG to Phospholipid ratio. I 
used a ratio of 500:1 and got aLDs on the size of a few microns in diameter. It is 
possible that increasing the TAG:PL ratio could lead to larger aLDs and more surface 
area for the ABHD5 to bind, oligomerize, and induce membrane shape changes; 





















Project 3: Droplet Embedded Vesicles:   
Introduction: 
 Droplet Embedded Vesicles (DEVs) are a model membrane system in which 
Giant Unilamellar Vesicles (GUVs), large spherical membrane structures typically larger 
than 1 micron in diameter, are mixed with neutral lipids to form a structure that has 
neutral lipid sequestered in between the leaflets of the bilayer (Figure 11a).12  When 
sufficient neutral lipid is between the leaflets, a protrusion forms which looks like a lens 
or a bud (Figure 11b).13 This system is representative of LD formation that occurs at the 
ER. I wanted to learn if upon the addition of ABHD5, there were physical membrane 
shape changes or enhanced sorting of ABHD5 at the site of the curvature where the 
neutral lipid is present. This would further support the role that ABHD5 alters membrane 
shape to allow PNPLA2 to carry out lipolysis.  
 
Figure 10: a) aLDs without  protein b) aLDs with the addition of ABHD5. aLDs in both sets of images 
demonstrate similar circularity and shape indicating ABHD5 has not caused a morphological change in the 
sample. Images on the left were taken with 𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence, and images on the right were 
taken with white-light transmission. 
a)   
b)   
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Methods:   
 DEVs were constructed by mixing a neutral lipid nano emulsification with Giant 
Unilamellar Vesicles.12 Lipid stock solution used to make GUVS consisted of 74.4% 
DOPC (w/w), 24.4%(DOPE), and 0.2% DOPE-CY5(w/w) all purchased from Avanti 
Polar Lipids®. To prepare GUVs, two ITO plates were acquired and tested with a 
multimeter to determine conducting and nonconducting sides. The plates were cleaned 
with ethanol, dried off with nitrogen gas, and placed in a vacuum for five minutes. After 
being cleaned, a square shaped silicone spacer, with a slit at one of the edges, was 
placed on the conducting side of one of the plates. 30 µl of the lipid stock solution was 
placed on the plate followed by spin coating in increments of two to three drops to have 
the lipids stick to the glass while removing the solvent. Vacuum grease was applied to 
the edges of the spacer and the other ITO plate was attached. A 200 mM solution of 
sucrose was injected quickly into the chamber through the slit in the spacer till the 
chamber was full of the solution: it is important in this process to ensure that no air 
bubbles are present as this will hinder GUV formation. The chamber was then 
connected to a waveform generator with a frequency of 10Hz and an amplitude of 4Vpp 
for two hours. The chamber was then disconnected and the solution of GUVs was 
extracted, placed in an Eppendorf tube, and left on a rotator in 4-degree fridge.    
  The nano-emulsification was made by mixing 70ul of intracellular buffer (IB), 
filtered with a 0.45µm filter, with 5µl of triolein; the volume of triolein was increased to 
150ul in later experiments to improve DEV formation. In a second tube, 50µl of the GUV 
solution was placed. The tube with the IB and triolein, was then vortexed and sonicated 
for 10s two times until the nano-emulsification had a creamy, cloudy texture. With a 
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truncated 200µl micropipette tip, 50µl was rapidly collected and gently poured into the 
tube with the GUVs. The solution was mixed for about 2-3 minutes, during which the 
volume of the nano-emulsification was sucked and then released in the solution while 
moving the micropipette tip back and forth. This mixing process is what helps to 
incorporate the triolein into the GUVs to form DEVs. The solution was then placed on a 
mixer for at least five minutes to allow for further mixing. DEV samples were placed on a 
96 well plate that had been passivated with a 10% (w/w) BSA solution. The images 
were collected on the Olympus IX71 epifluorescence microscope and an Olympus 
spinning disk confocal microscope. To ensure that DEVs were being seen, white light 
imaging was used because the index of refraction of oil is much higher and provides 
good contrast. Epifluorescence images were analyzed using ImageJ and the confocal 
images were analyzed with QuPath and ImageJ. 
Results and Discussion:   
 In the first experiment, the DEVs were plated and ABHD5 was flowed into the 
well similar to the SLB experiment. Drastic changes in the sample started to take place, 
even at low concentrations of ABHD5, such as 0.4nM. The spot in the sample where the 
protein was being injected into the well displaced/destroyed DEVs, meanwhile spots 
further away from the point of injection were more intact (Figure 13). To confirm this was 
due to flow, a control experiment in which only IB was injected, in which ABHD5 is 
suspended, confirmed the heterogeneity in the sample based on where the liquid was 
injected. Another issue with the sample was the size of the DEVs (Figure 14). The 
portion of the DEV where the TO is concentrated is only 1μm in diameter compared to 
the GUV which is 4μm (Figure 12). Having a DEV on this size scale can make it difficult 
  Junedi 19 
 
to see the ABHD5 sorting. Furthermore, few DEVs were being formed when including 
only 5ul of triolein. To remedy the first issue, ABHD5 was added to the DEVs in an 
Eppendorf tube and placed on a spinner for thirty minutes to allow for binding. To 
increase the size of the triolein droplet attached to the GUV, the volume of triolein 
injected to make the nano-emulsification was increased to 100μl. This did lead to 
greater triolein incorporation in the GUV and consequently larger DEVs (Figure 15).  
 When ABHD5 was added to the DEVs, no apparent physical changes were 
occurring similar to the aLD project. However, to get a better understanding of whether 
the protein was sorting to the site of curvature, the sample was imaged on a confocal 
microscope. Images were acquired in white-light transmission, 𝜆𝑒𝑥𝑐 =  647𝑛𝑚  for the 
Cy5 fluorescent lipids, and 𝜆𝑒𝑥𝑐 =  440𝑛𝑚  for ABHD5 CFP. Preliminary results indicate 
that ABHD5 is binding to the portion of the DEV where triolein is concentrated. When 
ABHD5 was added to the DEV sample at a concentration of 50nM, in the CFP channel 
there was some preferential sorting of ABHD5 to the neutral lipid bud in the DEV (Figure 
16); this is quantified by the large spike in fluorescence intensity shown in the line scan 
histogram in the CFP color channel (Figure 16). This result was compared to the line 
scan histogram of a DEV with the addition of the protein buffer as a control. The control 
does not show any increased fluorescence signal. The signal the histogram from the 
control recorded matches the background signal present in areas of the sample where 
the DEV is not present in the (Figures 17,18). Although no large-scale membrane 
changes were observed with the addition of ABHD5, the preferential sorting to the site 
of the neutral lipid bud is an encouraging preliminary result that supports the hypothesis 
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that ABHD5 oligomerizes on the surface of an LD and creates packing defects to 
liberate fatty acids. 
 One of the interesting aspects of the system are the different tensions that exist 
in the DEV: bilayer tension and monolayer tension (Figure 19).15 The literature shows 
that lower bilayer and monolayer tensions in the system lead to more budding activity 
(i.e. neutral lipid protrusion in the bilayer is more spherical). Experimentally this was 
confirmed by varying the phospholipid PC:PE ratio in a variety of systems. For both 
monolayer and bilayer tensions, reduced tensions via reduced PC:PE ratios led to 
increased egression of the neutral lipids from the bilayer indicating that at lower 
tensions, the budding activity occurs.15 In the computational effort, a PC bilayer with a 
triolein lens was simulated with molecular dynamics. The results showed as the bilayer 
tension was increased, neutral lipid molecules left the lens.15 The conclusions from 
these experiments are very important to keep in mind as membrane tension plays a role 
in the size of the lipid droplet formation and hence how well the ABHD5 membrane 
shape changes are resolved. 
 To improve the results of the experiment, it would be very useful to increase the 
size of the lipid droplet portion of the DEV. Attempts at this were made in this project by 
increasing the volume of triolein, however it may be pertinent to add even more triolein 
to improve incorporation into the DEV. Furthermore, lowering the tension in the DEV 
may increase activity of ABHD5, as less energy may be required to remodel the 
membrane. This can be done by lowering the ratio of PC:PE in the sample.15  
 












Figure 11: a) Incorporation of triolein into the GUV to form a DEV.12 b) Low bilayer tension 
leads to the formation of spherical bud. High bilayer tension leads to a lens like shape. These 







Figure 12: White-light transmission(left) and 𝜆𝑒𝑥𝑐 =  647𝑛𝑚  epifluorescence image of a DEV 
(right). The bright white circle present in the left panel is the lipid droplet attached to the DEV. It 



















































Figure 13:) White-light transmission images of DEVs (left) and  
𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence images (right). a) Before ABHD5 was 
flowed into the sample. b) Spot in the well where ABHD5 was 
injected. The DEVs and GUVs have been displaced and/or destroyed 
due to the perturbation from the flow.c) In the same well as (b) but 
imaged away from the point of injection. Density of GUVs and DEVs 
visible in the right image confirm the flow of the liquid is disturbing the 
sample making observing protein induced changes very difficult.  





























Figure 14: Injection of IB into the well of DEVS as a 
control experiment. Left panel shows point of 
injection. Right panel shows a spot further from 
injection. Difference in the density of GUVs and 
DEVs confirms flow-based perturbations were 
disturbing the sample. Both images were taken with 
𝜆𝑒𝑥𝑐 =  647𝑛𝑚 epifluorescence. 
Figure 15: a) Image of larger DEVs 
present after the increase of triolein in the 
nano-emulsification. b)  Various images of 
aLDs with the increased triolein 
incorporation. All images were taken with 
the white-light transmission. 
a) b) 





























a)                   b)                      c) 
Figure 16: a) Image of a DEV with 𝜆𝑒𝑥𝑐 =  440𝑛𝑚 
epifluorescence. b) Zoomed in section of the blue box in (a). 
The blue line are the locations used to create the histogram. 
Images were acquired with a spinning disk confocal 
microscope. c) Line scan histogram of (b). There is a very large 
spike in fluorescence intensity in the middle. This indicates that 
ABHD5 is sorting to lipid droplet in the DEV. 
a)                                           b)  
Figure 17: a) White-light transmission image of a DEV. Only 
the protein buffer was added to this sample as a control. b) 
𝜆𝑒𝑥𝑐 =  440𝑛𝑚 confocal image of (a). Both images were 
acquired with a spinning disk confocal microscope. 

















Figure 18: a) Zoomed in white-light transmission image of a DEV from the figure 16a as indicated 
by the blue box. Oil in the lipid droplet provides the high contrast in the image due to its index of 
refraction. b) 𝜆𝑒𝑥𝑐 =  440𝑛𝑚 confocal image of (a). Both images were acquired with a spinning disk 
confocal microscope. c) Line scan histogram of (b) as indicated by the blue line. The histogram 
shows fluctuations in fluorescence intensity in the range of 250-300 a.u. This is the same level of 
fluorescence intensity seen in figure 16c in the areas away from the DEV indicating sorting of 
ABHD to the DEV. 
Figure 19:  The various tensions that exist in a droplet embedded vesicle. γb shows the tension 
due to the bilayer and  γm shows the tension due to the monolayer. Lower tensions lead to more 
spherical protrusions mimicking the LD.15 
Figure 20: The various compounds proteins and compounds involved in lipolysis. ABHD5 is 
in its repressed state when bound to PLIN-1. Upon the addition of the SR compound, it 
begins to oligomerize and remodel the monolayer exposing packing defects. This then 
allows the enzymatically active protein PNPLA2 to hydrolyze the release of a fatty acid. LC-
CoA is a compound that stabilizes the repressed state of ABHD5, which binds to PLIN-1. 
a)                 b)                          c) 
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Future Work:  
 ABHD5 is not the only protein/molecule involved in lipolysis. PLIN-1 is a perilipin 
protein that binds to ABHD5 and represses its function. Our collaborator, Dr. 
Granneman, discovered that there are synthetic ligands (SR compounds) which can 
modulate the activity of ABHD5 by increasing its dissociation from PLIN1 (Figure 20).16 
The next step in my research would be to confirm these findings. An experiment to 
confirm these findings would be to compare how ABHD5 binds and remodels the 
membrane in the presence of these compounds on a DEV. I expect to see the activity 
and sorting of ABHD5 to the site of curvature to decrease upon the addition of PLIN-1. 
When SR compound is added to the sample in this state, activity of ABHD5 should 
increase again. Confirming these findings on the DEV would further support the 
hypothesis that ABHD5 has membrane remodeling activity. 
 An interesting direction for the work is trying to understand the energies at the 
protein-protein interaction between oligomers of ABHD5. What kinds of bonds are being 
formed between the proteins? How much energy is released in the formation of the 
bonds? Do different phospholipid compositions enhance or hinder oligomer formation of 
ABHD5? What membrane tensions do the proteins operate at best? Knowing that 
ABHD5 has non-enzymatic activity illustrates the need to understand the protein-protein 
interactions between the oligomers. There may be pertinent information in this part of 
the problem that can help to regulate the process of lipolysis. 
Conclusion:    
 The mechanism by which lipolysis functions is an important process that has 
important health implications. The complexity of live cells makes understanding the 
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relevant membrane shape change phenomenon difficult. However, with model 
membrane systems employed in this paper, these changes can be resolved much more 
easily. The idea that ABHD5 creates packing defects in the membrane exposing the 
neutral lipids to the enzymatically active PNPLA2 was tested in this project by adding 
ABHD5 to various model membrane systems. The SLB system showed drastic 
morphology changes by the way of vesiculation and fracturing of lipid buds and tubules. 
Furthermore, increased fluorescence intensity of the protein where buds and tubules 
were in the sample is encouraging evidence that ABHD5 remodels membranes. 
Preliminary results from the confocal images of the addition of ABHD5 to DEVs, indicate 
that ABHD5 is sorting the protrusion in the GUV where neutral lipid has aggregated. 
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